Oropharyngeal Cancer
Top stories in oncology 2024: Cannabis, vaping increase cancer risk
As 2024 comes to a close, Healio is pleased to present our most widely read oncology and hematology content from the past 12 months.
Mouthwash test could detect risk for recurrence of head and neck cancer
A mouthwash-based biomarker test has demonstrated efficacy for detecting risk of head and neck cancer recurrence, according to results of a nonrandomized clinical trial.
‘Sobering’ data show excessive cannabis use increases risk for head and neck cancer
Individuals with cannabis-related disorder exhibited increased risk for head and neck cancer, results of a retrospective cohort study showed.
HPV vaccination linked to lower risk for related cancers among men
Men vaccinated for HPV less frequently developed all related cancers, particularly head and neck cancers, according to findings scheduled for presentation at ASCO Annual Meeting.
High-risk sexual behavior alone may not increase risk for oropharyngeal cancer
High-risk sexual behavior may not be the primary contributor to the development of oropharyngeal squamous cell carcinoma, according to data published in Cancers.
Liquid biopsy may aid in diagnosis, surveillance of HPV-associated oropharyngeal cancer
Tumor tissue-modified viral-HPV DNA testing demonstrated 100% specificity in both diagnosis and surveillance of HPV-associated oropharyngeal squamous cell carcinoma in a clinical setting, according to a study.
Robotic surgery linked to longer survival vs. chemoradiation for oropharyngeal cancer
Primary transoral robotic surgery appeared associated with greater risk for short-term dysphagia compared with primary radiotherapy or chemoradiotherapy among patients with T1-T2 oropharyngeal squamous cell carcinoma, study results showed.
Treatment for HPV-positive oropharyngeal cancer varies by facility type
DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results.
Research spotlight: Innovative strategies guide head and neck cancer treatment
April is Head and Neck Cancer Awareness Month.
Mid-treatment imaging guides radiation de-escalation in oropharynx cancer
Mid-treatment imaging helped guide de-escalation of radiation for certain patients with oropharynx cancer, according to phase 2 study results presented at Multidisciplinary Head and Neck Cancers Symposium.